Werewolf Therapeutics Statistics
NASDAQ: HOWLHealthcareBiotechnologyUSD
0.91-0.0101 (-1.10%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Werewolf Therapeutics by the numbers
Werewolf Therapeutics has a market capitalization of $44.2 million based on 48.60M shares outstanding. With trailing EPS of $-0.73, Werewolf Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.2% above its 50-day average and 40.0% above its 200-day average.
Average daily trading volume is 6.80M shares, or about $6.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HOWL valuation vs. peer median
| Metric | HOWL | Peer median | Difference |
|---|---|---|---|
| Market cap | $44.23M | $46.67M | -5% |
| Avg. volume | 6.80M | 117.69K | +5680% |
Peer median across 8 companies: TIL, TVGN, GRCE, CELU, ELTX, DWTX, VERU, IMA.
Valuation
- Market cap
- $44.23M
- EPS (TTM)
- $-0.73
- Shares outstanding
- 48.60M
Price and trading
- Previous close
- 0.9201
- Open
- 0.92
- Day range
- 0.907 – 0.9281
- 52-week range
- 0.27 – 1.94
- 52-week change
- -51.60%
- 50-day moving average
- 0.7637
- 200-day moving average
- 0.6498
- Beta
- —
- Volume
- 631.35K
- Average volume
- 6.80M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 44.23M
- Forward Pe
- -1.54
- Eps
- -0.73
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.94
- Week52 Low
- 0.27
- Avg Volume
- 6.80M
- Shares Outstanding
- 48.60M
- Ma50
- 0.76
- Ma200
- 0.65
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -53.02%
- Pct From52w Low
- 237.04%